Showing results (81-90 of 152) with videos related to
Sort By:
Pageof 16
Expert Opinion on Biological Therapy|November 15, 2024
Immunobiology of biliary tract cancer and recent clinical findings in approved and upcoming immune checkpoint inhibitorsCarmelo Laface, Emanuela Fina, Angela Dalia Ricci, et al.International Journal of Clinical Oncology|April 2, 2024
Albumin-myosteatosis gauge as a prognostic factor in patients with advanced pancreatic cancer undergoing first-line chemotherapyTaha Koray Sahin, Yakup Ozbay, Ahmet Yasir Altunbulak, et al.Journal of Clinical Medicine|September 9, 2022
Blood Based Biomarkers as Predictive Factors for Hyperprogressive DiseaseHasan Cagri Yildirim, Deniz Can Guven, Oktay Halit Aktepe, et al.Medicine|May 5, 2023
Do statins enhance the antitumor effect of trastuzumab emtansine (T-DM1)?: Real-life cohortArif Akyildiz, Deniz Can Guven, Hasan Cagri Yildirim, et al.The Turkish Journal of Gastroenterology : the Official Journal of Turkish Society of Gastroenterology|December 8, 2021
Correlation Between THSD7A Expression and Tumor Characteristics of Azoxymethane-Induced Colon Cancer Model in RatsOktay Halit Aktepe, Taha Koray Sahin, Gurkan Guner, et al.Journal of Clinical Medicine|April 26, 2025
Clinical Characteristics and Management of Patients Admitted to the Supportive Care Clinic and Predisposing Factors of Unplanned Hospital Readmission: Single-Center ExperienceOnur Baş, Mert Tokatlı, Naciye Güdük, et al.International Journal of Clinical Oncology|October 18, 2021
HER2-low breast cancer could be associated with an increased risk of brain metastasisDeniz Can Guven, Mehmet Burak Kaya, Burak Fedai, et al.Expert Review of Anticancer Therapy|February 21, 2023
Emerging treatment strategies in hepatobiliary cancerDeniz Can Guven, Hasan Cagri Yildirim, Elvin Chalabiyev, et al.Clinics and Research in Hepatology and Gastroenterology|June 23, 2023
Prognostic and predictive value of tumor infiltrating lymphocytes in combination with systemic inflammatory markers in colon cancerSafa Can Efil, Gunes Guner, Deniz Can Guven, et al.Journal of Cancer Research and Clinical Oncology|August 12, 2022
The benefit of treatment beyond progression with immune checkpoint inhibitors: a multi-center retrospective cohort studyDeniz Can Guven, Emre Yekeduz, Enes Erul, et al.Pageof 16